GSK to sell cancer drug unit to Novartis, buy Novartis vaccines

04/22/2014 | Bloomberg

GlaxoSmithKline is selling its cancer drug unit to Novartis for up to $16 billion. Novartis will in turn sell most of its vaccines unit to Glaxo for $7.1 billion, and the two drugmakers will form a consumer health venture. Eli Lilly and Co. agreed to buy Novartis' animal health unit for $5.4 billion.

View Full Article in:


Published in Briefs: